GlobeImmune's Series E Round

GlobeImmune raised a round of funding on January 22, 2010.

GlobeImmune is a biopharmaceutical company focused on developing products for the treatment of infectious disease and and oncology based on its proprietary Tarmogen platform. Tarmogens are believed to…

Articles about GlobeImmune's Series E Round: